The present invention provides the use of escin for the manufacture of a pharmaceutical preparation for the treatment diseases mediated or caused by activated granulocytes, preferably a type I or type III allergy or septic shock.
申请公布号
WO2008015007(A3)
申请公布日期
2008.04.03
申请号
WO2007EP06870
申请日期
2007.08.03
申请人
MARINOMED BIOTECHNOLOGIE GMBH;GRASSAUER, ANDREAS;PRIESCHL, EVA